Pharmaceutical Supply Chain Strategy in a Tariff-Driven Era
The pharmaceutical supply chain strategy has fundamentally shifted as trade tariffs, pricing mandates, and global policy disruptions expose deep vulnerabilities across the value chain. Rising API costs, drug shortages, and regulatory unpredictability are forcing companies to rethink sourcing, manufacturing, and risk frameworks. For more info: https://www.zs.com/insights/us-pharma-policy-strategies-to-future-proof-your-supply-chain
Pharmaceutical Supply Chain Strategy in a Tariff-Driven EraThe pharmaceutical supply chain strategy has fundamentally shifted as trade tariffs, pricing mandates, and global policy disruptions expose deep vulnerabilities across the value chain. Rising API costs, drug shortages, and regulatory unpredictability are forcing companies to rethink sourcing, manufacturing, and risk frameworks. For more info: https://www.zs.com/insights/us-pharma-policy-strategies-to-future-proof-your-supply-chain
0 Σχόλια
0 Μοιράστηκε
29 Views
0 Προεπισκόπηση
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)